Cefiderocol dominates in vitro activity against Indian carbapenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa
Bioinformation · 31.07.2026 · 22 (7) · 3947-3953
DOI: 10.6026/973206300223947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.07.2026. Verfasst von Mallika Sengupta.
Abstract (Originalsprache)
Carbapenem-resistant Pseudomonas aeruginosa (CRPA) and Acinetobacter baumannii (CRAB) are increasingly common in India, where treatment options remain largely limited to polymyxins, necessitating evaluation of newer therapeutic agents. In this prospective study, 11 CRPA and 29 CRAB isolates were characterized to determine carbapenem resistance mechanisms and in vitro activity of cefiderocol, aztreonam-avibactam, imipenem-relebactam, meropenem-vaborbactam, eravacycline and colistin was determined. Phenotypic metallo-β-lactamase production was detected in 64% of CRPA and 96% of CRAB isolates, while blaNDM was identified in 82% and 93% of CRPA and CRAB isolates. Cefiderocol demonstrated the highest in vitro activity, with susceptibility in all CRPA isolates and 86.2% of CRAB isolates, whereas imipenem-relebactam, meropenem-vaborbactam and eravacycline showed limited activity. Thus, data shows the cefiderocol was the most promising therapeutic option against carbapenem-resistant P. aeruginosa and A. baumannii in this Indian cohort, highlighting the urgent need to improve its clinical availability.
Zitieren
APA
Sengupta, M. (2026). Cefiderocol dominates in vitro activity against Indian carbapenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Bioinformation, 22(7), 3947-3953. https://doi.org/10.6026/973206300223947
Vancouver
Sengupta M. Cefiderocol dominates in vitro activity against Indian carbapenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Bioinformation. 2026;22(7):3947-3953. doi:10.6026/973206300223947
BibTeX
@article{Sengupta2026,
author = {Sengupta, Mallika},
title = {Cefiderocol dominates in vitro activity against Indian carbapenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {7},
pages = {3947--3953},
doi = {10.6026/973206300223947}
}
EUVIMED